Feb 9 (Reuters)-
Garna Biosciences Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2023 Dec 31, 2022 Dec 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.63 1.39 925 mln
(+17.2 pct) (-31.3 pct) (-43.0 pct)
Operating loss 1.12 loss 1.27 loss 2.20
Recurring loss 1.13 loss 1.28 loss 2.21
Net
Net loss 1.15 loss 1.35 loss 2.23
EPS loss 68.62 yen loss 99.10 yen loss 129.81 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Garna Biosciences Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T